These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18166271)

  • 81. Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P.
    Nikolaus S; Huston JP; Hasenöhrl RU
    Neurosci Lett; 2000 Mar; 283(1):37-40. PubMed ID: 10729628
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of maternal separation on brain nociceptin/orphanin FQ peptide levels in male Wistar rats.
    Ploj K; Roman E; Nylander I
    Pharmacol Biochem Behav; 2002 Aug; 73(1):123-9. PubMed ID: 12076731
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Noninteractive effects of diazepam and amygdaloid lesions in two animal models of anxiety.
    Treit D; Pesold C; Rotzinger S
    Behav Neurosci; 1993 Dec; 107(6):1099-105. PubMed ID: 8136064
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Anxiolytic-like effects of mirogabalin, a novel ligand for α
    Murasawa H; Kobayashi H; Yasuda SI; Saeki K; Domon Y; Arakawa N; Kubota K; Kitano Y
    Pharmacol Rep; 2020 Jun; 72(3):571-579. PubMed ID: 32270470
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Anxiolytic profiles of alprazolam and ethanol in the elevated plus-maze test and the early acquisition of shuttlebox avoidance.
    Prunell M; Escorihuela RM; Fernández-Teruel A; Núñez JF; Tobeña A
    Pharmacol Res; 1994; 29(1):37-46. PubMed ID: 7911239
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions.
    Treit D; Menard J
    Behav Neurosci; 1997 Jun; 111(3):653-8. PubMed ID: 9189280
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A new synthesis of the ORL-1 antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397) and activity in a calcium mobilization assay.
    Smith ED; Ariane Vinson N; Zhong D; Berrang BD; Catanzaro JL; Thomas JB; Navarro HA; Gilmour BP; Deschamps J; Carroll FI
    Bioorg Med Chem; 2008 Jan; 16(2):822-9. PubMed ID: 17976996
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Anxiolytic-like effect of a novel peptide isolated from the venom of the social wasp Synoeca surinama.
    Gomes FM; Paniago CK; Freire DO; Souza AC; Lima MR; Oliveira-Júnior NG; Franco OL; Mortari MR
    Toxicon; 2016 Nov; 122():39-42. PubMed ID: 27664832
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A new synthetic approach to 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-benzimidazol-2-one(J-113397), the first non-peptide ORL-1 receptor antagonist.
    De Risi C; Piero Pollini G; Trapella C; Peretto I; Ronzoni S; Giardina GA
    Bioorg Med Chem; 2001 Jul; 9(7):1871-7. PubMed ID: 11425589
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Synthesis and evaluation of 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[11C]ethyl-1,3-dihydro-2H-benzimidazol-2-one as a brain ORL1 receptor imaging agent for positron emission tomography.
    Ogawa M; Hatano K; Kawasumi Y; Ishiwata K; Kawamura K; Ozaki S; Ito K
    Nucl Med Biol; 2003 Jan; 30(1):51-9. PubMed ID: 12493543
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety.
    Treit D; Pesold C; Rotzinger S
    Behav Neurosci; 1993 Oct; 107(5):770-85. PubMed ID: 8280387
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Anxiolytic effects of administration of a commercially available prebiotic blend of galacto-oligosaccharides and beta glucans in Sprague-Dawley rats.
    Gall AJ; Griffin GD
    Benef Microbes; 2021 Aug; 12(4):35-43. PubMed ID: 34169805
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Derivatives of 3, 4, 5-Trimethoxycinnamic Acid Ameliorate Stress-Induced Anxiety in Mice and Rats.
    Hong E; Min HK; Lim H; Gu SM; Jabborov A; Yayeh T; Kim M; Park WK; Jung JC; Yun J; Oh S
    Mol Neurobiol; 2023 May; 60(5):2737-2748. PubMed ID: 36715919
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model.
    László K; Kiss O; Vörös D; Mintál K; Ollmann T; Péczely L; Kovács A; Zagoracz O; Kertes E; Kállai V; László B; Hormay E; Berta B; Tóth A; Karádi Z; Lénárd L
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203614
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety.
    McNaughton N; Gray JA
    J Affect Disord; 2000 Dec; 61(3):161-76. PubMed ID: 11163419
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Recurrent Hypoglycemia Increases Anxiety and Amygdala Norepinephrine Release During Subsequent Hypoglycemia.
    McNay E
    Front Endocrinol (Lausanne); 2015; 6():175. PubMed ID: 26635724
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Effect of a novel anxiolytic SM-346 on the bioelectric activity of the cerebral cortex of MR and MNRA rats].
    Kozhechkin SN; Viglinskaia IV; Seredenin SB; Sviderskaia NE; Korol'kova TA; Koshtoiants OKh; Kozhedub RG
    Biull Eksp Biol Med; 1999 Nov; 128(11):500-3. PubMed ID: 10640231
    [No Abstract]   [Full Text] [Related]  

  • 98. Effect of amygdalar opioids on the anxiolytic properties of ethanol.
    Wilson MA; Burghardt PR; Lugo JN; Primeaux SD; Wilson SP
    Ann N Y Acad Sci; 2003 Apr; 985():472-5. PubMed ID: 12724179
    [No Abstract]   [Full Text] [Related]  

  • 99. Correction to: Electrophysiological Actions of N/OFQ.
    Winters BL; Christie MJ; Vaughan CW
    Handb Exp Pharmacol; 2019; 254():417. PubMed ID: 31152275
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Rostromedial tegmental nucleus nociceptin/orphanin FQ (N/OFQ) signaling regulates anxiety- and depression-like behaviors in alcohol withdrawn rats.
    Li W; Ren Z; Tang Y; Fu Y; Sun S; Ding R; Hou J; Mai Y; Zhan B; Zhu Y; Zuo W; Ye JH; Fu R
    Neuropsychopharmacology; 2023 May; 48(6):908-919. PubMed ID: 36329156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.